Skip to content
EN · DE · 中文 Log in
  • Impact 2022
  • Our Ventures
  • Submit invention
    • Your Invention
    • Assessment
    • FAQ
  • Investors
    • Investments
    • NLC Funds
  • About NLC
    • Our Team
    • Partners
    • News
    • Impact & ESG Policy
    • Careers
    • Contact
Log in
EN · DE · 中文

Knowledge Papers

25/06/2020

How healthtech innovations arise during the COVID-19 crisis

At the start of the COVID-19 outbreak in Europe, NLC developed a website for people to share COVID-19 related ideas and innovations. With over…

Read more
02/06/2020

Do’s and don’ts when filing a patent

One of the most important, yet also most daunting and complicated tasks in the process of bringing an invention to the market, is securing…

Read more
28/03/2020

Corona pandemic – the call for healthtech entrepreneurship

There are many fantastic examples in history of devastating crises that have led to a great wave of innovation. Perhaps the most famous example…

Read more
05/09/2019

Concord Neonatal achieves CE mark for the Concord Birth Trolley

PRESS RELEASE: Leiden, 4 September 2019 – Today Concord Neonatal is delivering brand-new Concord Birth Trolley’s to a number of Dutch hospitals, after achieving…

Read more
03/07/2019

Concord Neonatal just launched a great animation video explaining why we are so passionate about Concord

Read more
12/06/2019

Interview Bert Arjan Millenaar with Paul van Liempt

Interview (in Dutch but subtitled in English) with Paul van Liempt, explaining the NLC – The Healthtech Venture Builder way of bringing science to life….

Read more

Logo

NLC logo

Menu

  • Impact 2022
  • Our Ventures
  • Submit invention
    • Your Invention
    • Assessment
    • FAQ
  • Investors
    • Investments
    • NLC Funds
  • About NLC
    • Our Team
    • Partners
    • News
    • Impact & ESG Policy
    • Careers
    • Contact

Contact

info@nlc.health
+31 20 244 06 23

Paasheuvelweg 25-D5
1105 BP Amsterdam
The Netherlands

Newsletter

Certified

© NLC 2022
General Terms and Conditions
Privacy Statement
Disclaimer

Newsletter